Molecular physiology of mammalian glucokinase

Cellular and Molecular Life Sciences

Volumn 66, Issue 1, 2009, Pages 27-42

  Iynedjian, P B ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Diabetes; Glucokinase; Glucose metabolism; Hepatocyte; Hexokinase; Insulin; Islet of Langerhans; MODY

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; ANTIDIABETIC AGENT; BRAIN ENZYME; ENZYME ACTIVATOR; FRUCTOSE 2,6 BISPHOSPHATASE; GLUCOKINASE; GLUCOSE; INSULIN; LIVER ENZYME; NITRIC OXIDE SYNTHASE; PANCREAS ENZYME; PHOSPHATASE; PROPIONYL COENZYME A CARBOXYLASE; PROTEIN BAD; REGULATOR PROTEIN; RO 28 1675; UBIQUITIN; UNCLASSIFIED DRUG;

BRAIN; DRUG TARGETING; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INDUCTION; ENZYME KINETICS; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME STRUCTURE; FATTY LIVER; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT SYSTEM; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS; INSULIN RELEASE; INSULIN RESISTANCE; LIPOGENESIS; LIVER; MATURITY ONSET DIABETES MELLITUS; MISSENSE MUTATION; MITOCHONDRIAL MEMBRANE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SINGLE DRUG DOSE; TRANSCRIPTION INITIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BRAIN; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; GLUCOSE; HEXOKINASE; HOMEOSTASIS; HUMANS; INSULIN; ISLETS OF LANGERHANS; LIVER; MITOCHONDRIAL MEMBRANES; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY;

MAMMALIA;

EID: 58149525327     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8322-9     Document Type: Review

References (130)

1. Cardenas, M. L., Cornish-Bowden, A. and Ureta, T. (1998) Evolution and regulatory role of the hexokinases. Biochim. Biophys. Acta 1401, 242-264.
2. Kawai, S., Mukai, T., Mori, S., Mikami, B. and Murata, K. (2005) Hypothesis: structures, evolution, and ancestor of glucose kinases in the hexokinase family. J. Biosci. Bioeng. 99, 320-330.
3. Ronimus, R. S. and Morgan, H. W. (2004) Cloning and biochemical characterization of a novel mouse ADP-dependent glucokinase. Biochem. Biophys. Res. Commun. 315, 652-658.
4. Froguel, P., Vaxillaire, M., Sun, F., Velho, G., Zouali, H., Butel, M. O., Lesage, S., Vionnet, N., Clement, K., Fougerousse, F. and et al. (1992) Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356, 162-164.
5. Hattersley, A. T., Turner, R. C., Permutt, M. A., Patel, P., Tanizawa, Y., Chiu, K. C., O'Rahilly, S., Watkins, P. J. and Wainscoat, J. S. (1992) Linkage of type 2 diabetes to the glucokinase gene. Lancet 339, 1307-1310.
6. Iynedjian, P. B. (1993) Mammalian glucokinase and its gene. Biochem. J. 293 (Pt 1), 1-13.
7. Printz, R. L., Magnuson, M. A. and Granner, D. K. (1993) Mammalian glucokinase. Annu. Rev. Nutr. 13, 463-496.
8. Wilson, J. E. (2003) Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 206, 2049-2057.
9. Cardenas, M. L., Rabajille, E. and Niemeyer, H. (1978) Maintenance of the monomeric structure of glucokinase under reacting conditions. Arch. Biochem. Biophys. 190, 142-148.
10. Moukil, M. A. and Van Schaftingen, E. (2001) Analysis of the cooperativity of human beta-cell glucokinase through the stimulatory effect of glucose on fructose phosphorylation. J. Biol. Chem. 276, 3872-3878.
11. Monasterio, O. and Cardenas, M. L. (2003) Kinetic studies of rat liver hexokinase D ('glucokinase') in non-co-operative conditions show an ordered mechanism with MgADP as the last product to be released. Biochem. J. 371, 29-38.
12. Storer, A. C. and Cornish-Bowden, A. (1977) Kinetic evidence for a 'mnemonical' mechanism for rat liver glucokinase. Biochem. J. 165, 61-69.
13. Heredia, V. V., Thomson, J., Nettleton, D. and Sun, S. (2006) Glucose-induced conformational changes in glucokinase mediate allosteric regulation: transient kinetic analysis. Biochemistry 45, 7553-7562.
14. Kim, Y. B., Kalinowski, S. S. and Marcinkeviciene, J. (2007) A pre-steady state analysis of ligand binding to human glucokinase: evidence for a preexisting equilibrium. Biochemistry 46, 1423-1431.
15. Kamata, K., Mitsuya, M., Nishimura, T., Eiki, J. and Nagata, Y. (2004) Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. Structure 12, 429-438.
16. Aleshin, A. E., Zeng, C., Bartunik, H. D., Fromm, H. J. and Honzatko, R. B. (1998) Regulation of hexokinase I: crystal structure of recombinant human brain hexokinase complexed with glucose and phosphate. J. Mol. Biol. 282, 345-357.
17. Zhang, J., Li, C., Chen, K., Zhu, W., Shen, X. and Jiang, H. (2006) Conformational transition pathway in the allosteric process of human glucokinase. Proc. Natl. Acad. Sci. USA 103, 13368-13373.
18. Van Schaftingen, E., Detheux, M. and Veiga da Cunha, M. (1994) Short-term control of glucokinase activity: role of a regulatory protein. Faseb. J. 8, 414-419.
19. Futamura, M., Hosaka, H., Kadotani, A., Shimazaki, H., Sasaki, K., Ohyama, S., Nishimura, T., Eiki, J. and Nagata, Y. (2006) An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism. J. Biol. Chem. 281, 37668-37674.
20. de la Iglesia, N., Veiga-da-Cunha, M., Van Schaftingen, E., Guinovart, J. J. and Ferrer, J. C. (1999) Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase. FEBS Lett. 456, 332-338.
21. Shiota, C., Coffey, J., Grimsby, J., Grippo, J. F. and Magnuson, M. A. (1999) Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase. J. Biol. Chem. 274, 37125-37130.
22. Bosco, D., Meda, P. and Iynedjian, P. B. (2000) Glucokinase and glucokinase regulatory protein: mutual dependence for nuclear localization. Biochem. J. 348 Pt 1, 215-222.
23. Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N., Vertommen, D., Andreelli, F., Viollet, B. and Hue, L. (2006) 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55, 865-874.
24. Toyoda, Y., Miwa, I., Kamiya, M., Ogiso, S., Nonogaki, T., Aoki, S. and Okuda, J. (1994) Evidence for glucokinase translocation by glucose in rat hepatocytes. Biochem. Biophys. Res. Commun. 204, 252-256.
25. Brown, K. S., Kalinowski, S. S., Megill, J. R., Durham, S. K. and Mookhtiar, K. A. (1997) Glucokinase regulatory protein may interact with glucokinase in the hepatocyte nucleus. Diabetes 46, 179-186.
26. Toyoda, Y., Miwa, I., Satake, S., Anai, M. and Oka, Y. (1995) Nuclear location of the regulatory protein of glucokinase in rat liver and translocation of the regulator to the cytoplasm in response to high glucose. Biochem. Biophys. Res. Commun. 215, 467-473.
27. Mukhtar, M., Stubbs, M. and Agius, L. (1999) Evidence for glucose and sorbitol-induced nuclear export of glucokinase regulatory protein in hepatocytes. FEBS Lett. 462, 453-458.
28. Farrelly, D., Brown, K. S., Tieman, A., Ren, J., Lira, S. A., Hagan, D., Gregg, R., Mookhtiar, K. A. and Hariharan, N. (1999) Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. Proc. Natl. Acad. Sci. USA 96, 14511-14516.
29. Grimsby, J., Coffey, J. W., Dvorozniak, M. T., Magram, J., Li, G., Matschinsky, F. M., Shiota, C., Kaur, S., Magnuson, M. A. and Grippo, J. F. (2000) Characterization of glucokinase regulatory protein-deficient mice. J. Biol. Chem. 275, 7826-7831.
30. Arden, C., Baltrusch, S. and Agius, L. (2006) Glucokinase regulatory protein is associated with mitochondria in hepatocytes. FEBS Lett. 580, 2065-2070.
31. Bustamante, E., Pediaditakis, P., He, L. and Lemasters, J. J. (2005) Isolated mouse liver mitochondria are devoid of glucokinase. Biochem. Biophys. Res. Commun. 334, 907-910.
32. Munoz-Alonso, M. J., Guillemain, G., Kassis, N., Girard, J., Burnol, A. F. and Leturque, A. (2000) A novel cytosolic dual specificity phosphatase, interacting with glucokinase, increases glucose phosphorylation rate. J. Biol. Chem. 275, 32406-32412.
33. Shiraishi, A., Yamada, Y., Tsuura, Y., Fijimoto, S., Tsukiyama, K., Mukai, E., Toyoda, Y., Miwa, I. and Seino, Y. (2001) A novel glucokinase regulator in pancreatic beta cells: precursor of propionyl-CoA carboxylase beta subunit interacts with glucokinase and augments its activity. J. Biol. Chem. 276, 2325-2328.
34. Baltrusch, S., Lenzen, S., Okar, D. A., Lange, A. J. and Tiedge, M. (2001) Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library. Identification of 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase as a novel interaction partner. J Biol Chem 276, 43915-43923.
35. Massa, L., Baltrusch, S., Okar, D. A., Lange, A. J., Lenzen, S. and Tiedge, M. (2004) Interaction of 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase (PFK-2/FBPase-2) with glucokinase activates glucose phosphorylation and glucose metabolism in insulin-producing cells. Diabetes 53, 1020-1029.
36. Baltrusch, S., Langer, S., Massa, L., Tiedge, M. and Lenzen, S. (2006) Improved metabolic stimulus for glucose-induced insulin secretion through GK and PFK-2/FBPase-2 coexpression in insulin-producing RINm5F cells. Endocrinology 147, 5768-5776.
37. Rizzo, M. A. and Piston, D. W. (2003) Regulation of beta cell glucokinase by S-nitrosylation and association with nitric oxide synthase. J. Cell. Biol. 161, 243-248.
38. Arden, C., Harbottle, A., Baltrusch, S., Tiedge, M. and Agius, L. (2004) Glucokinase is an integral component of the insulin granules in glucose-responsive insulin secretory cells and does not translocate during glucose stimulation. Diabetes 53, 2346-2352.
39. Bjorkhaug, L., Molnes, J., Sovik, O., Njolstad, P. R. and Flatmark, T. (2007) Allosteric activation of human glucokinase by free polyubiquitin chains and its ubiquitin-dependent cotranslational proteasomal degradation. J. Biol. Chem. 282, 22757-22764.
40. Danial, N. N., Gramm, C. F., Scorrano, L., Zhang, C. Y., Krauss, S., Ranger, A. M., Datta, S. R., Greenberg, M. E., Licklider, L. J., Lowell, B. B., Gygi, S. P. and Korsmeyer, S. J. (2003) BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424, 952-956.
41. Danial, N. N., Walensky, L. D., Zhang, C. Y., Choi, C. S., Fisher, J. K., Molina, A. J., Datta, S. R., Pitter, K. L., Bird, G. H., Wikstrom, J. D., Deeney, J. T., Robertson, K., Morash, J., Kulkarni, A., Neschen, S., Kim, S., Greenberg, M. E., Corkey, B. E., Shirihai, O. S., Shulman, G. I., Lowell, B. B. and Korsmeyer, S. J. (2008) Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat. Med. 14, 144-153.
42. Jetton, T. L., Liang, Y., Pettepher, C. C., Zimmerman, E. C., Cox, F. G., Horvath, K., Matschinsky, F. M. and Magnuson, M. A. (1994) Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J. Biol. Chem. 269, 3641-3654.
43. Shelton, K. D., Franklin, A. J., Khoor, A., Beechem, J. and Magnuson, M. A. (1992) Multiple elements in the upstream glucokinase promoter contribute to transcription in insulinoma cells. Mol. Cell. Biol. 12, 4578-4589.
44. Moates, J. M. and Magnuson, M. A. (2004) The Pal elements in the upstream glucokinase promoter exhibit dyad symmetry and display cell-specific enhancer activity when multimerised. Diabetologia 47, 1632-1640.
45. Moates, J. M., Nanda, S., Cissell, M. A., Tsai, M. J. and Stein, R. (2003) BETA2 activates transcription from the upstream glucokinase gene promoter in islet beta-cells and gut endocrine cells. Diabetes 52, 403-408.
46. Watada, H., Kajimoto, Y., Umayahara, Y., Matsuoka, T., Kaneto, H., Fujitani, Y., Kamada, T., Kawamori, R. and Yamasaki, Y. (1996) The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/ PDX-1 in its activation in HIT-T15 cells. Diabetes 45, 1478-1488.
47. Chakrabarti, S. K., James, J. C. and Mirmira, R. G. (2002) Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J. Biol. Chem. 277, 13286-13293.
48. Iynedjian, P. B., Marie, S., Wang, H., Gjinovci, A. and Nazaryan, K. (1996) Liver-specific enhancer of the glucokinase gene. J. Biol. Chem. 271, 29113-29120.
49. Iynedjian, P. B. (1998) Identification of upstream stimulatory factor as transcriptional activator of the liver promoter of the glucokinase gene. Biochem. J. 333 (Pt 3), 705-712.
50. Iynedjian, P. B., Gjinovci, A. and Renold, A. E. (1988) Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats. J. Biol. Chem. 263, 740-744.
51. Iynedjian, P. B., Marie, S., Gjinovci, A., Genin, B., Deng, S. P., Buhler, L., Morel, P. and Mentha, G. (1995) Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes. J. Clin. Invest. 95, 1966-1973.
52. Iynedjian, P. B., Roth, R. A., Fleischmann, M. and Gjinovci, A. (2000) Activation of protein kinase B/cAkt in hepatocytes is sufficient for the induction of expression of the gene encoding glucokinase. Biochem. J. 351 Pt 3, 621-627.
53. Ribaux, P. G. and Iynedjian, P. B. (2003) Analysis of the role of protein kinase B (cAKT) in insulin-dependent induction of glucokinase and sterol regulatory element-binding protein 1 (SREBP1)mRNAs in hepatocytes. Biochem. J. 376, 697-705.
54. Iynedjian, P. B. (2005) Lack of evidence for a role of TRB3/ NIPK as an inhibitor of PKB-mediated insulin signalling in primary hepatocytes. Biochem. J. 386, 113-118.
55. Wu, C., Okar, D. A., Stoeckman, A. K., Peng, L. J., Herrera, A. H., Herrera, J. E., Towle, H. C. and Lange, A. J. (2004) A potential role for fructose-2,6-bisphosphate in the stimulation of hepatic glucokinase gene expression. Endocrinology 145, 650-658.
56. Matsumoto, M., Ogawa, W., Teshigawara, K., Inoue, H., Miyake, K., Sakaue, H. and Kasuga, M. (2002) Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Diabetes 51, 1672-1680.
57. Foretz, M., Pacot, C., Dugail, I., Lemarchand, P., Guichard, C., Le Liepvre, X., Berthelier-Lubrano, C., Spiegelman, B., Kim, J. B., Ferre, P. and Foufelle, F. (1999) ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol. Cell. Biol. 19, 3760-3768.
58. Fleischmann, M. and Iynedjian, P. B. (2000) Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B/cAkt. Biochem. J. 349, 13-17.
59. Foretz, M., Guichard, C., Ferre, P. and Foufelle, F. (1999) Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. USA 96, 12737-12742.
60. Kim, S. Y., Kim, H. I., Kim, T. H., Im, S. S., Park, S. K., Lee, I. K., Kim, K. S. and Ahn, Y. H. (2004) SREBP-1c mediates the insulin-dependent hepatic glucokinase expression. J. Biol. Chem. 279, 30823-30829.
61. Stoeckman, A. K. and Towle, H. C. (2002) The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression. J. Biol. Chem. 277, 27029-27035.
62. Liang, G., Yang, J., Horton, J. D., Hammer, R. E., Goldstein, J. L. and Brown, M. S. (2002) Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277, 9520-9528.
63. Ono, H., Shimano, H., Katagiri, H., Yahagi, N., Sakoda, H., Onishi, Y., Anai, M., Ogihara, T., Fujishiro, M., Viana, A. Y., Fukushima, Y., Abe, M., Shojima, N., Kikuchi, M., Yamada, N., Oka, Y. and Asano, T. (2003) Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes 52, 2905-2913.
64. Hansmannel, F., Mordier, S. and Iynedjian, P. B. (2006) Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor. Biochem. J. 399, 275-283.
65. Roth, U., Jungermann, K. and Kietzmann, T. (2002) Activation of glucokinase gene expression by hepatic nuclear factor 4alpha in primary hepatocytes. Biochem. J. 365, 223-228.
66. Roth, U., Curth, K., Unterman, T. G. and Kietzmann, T. (2004) The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 279, 2623-2631.
67. Kietzmann, T., Roth, U., Freimann, S. and Jungermann, K. (1997) Arterial oxygen partial pressures reduce the insulin-dependent induction of the perivenously located glucokinase in rat hepatocyte cultures: mimicry of arterial oxygen pressures by H2O2. Biochem. J. 321 (Pt 1), 17-20.
68. Jungermann, K. and Kietzmann, T. (2000) Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 31, 255-260.
69. Emerling, B. M., Weinberg, F., Liu, J. L., Mak, T. W. and Chandel, N. S. (2008) PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). Proc. Natl. Acad. Sci. USA 105, 2622-2627.
70. Matsumoto, M., Pocai, A., Rossetti, L., Depinho, R. A. and Accili, D. (2007) Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor foxo1 in liver. Cell Metab. 6, 208-216.
71. Iynedjian, P. B., Ucla, C. and Mach, B. (1987) Molecular cloning of glucokinase cDNA. Developmental and dietary regulation of glucokinase mRNA in rat liver. J. Biol. Chem. 262, 6032-6038.
72. Iynedjian, P. B., Pilot, P. R., Nouspikel, T., Milburn, J. L., Quaade, C., Hughes, S., Ucla, C. and Newgard, C. B. (1989) Differential expression and regulation of the glucokinase gene in liver and islets of Langerhans. Proc. Natl. Acad. Sci. USA 86, 7838-7842.
73. Da Silva Xavier, G., Qian, Q., Cullen, P. J. and Rutter, G. A. (2004) Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic beta-cell glucose sensing revealed by RNA silencing. Biochem. J. 377, 149-158.
74. da Silva Xavier, G., Varadi, A., Ainscow, E. K. and Rutter, G. A. (2000) Regulation of gene expression by glucose in pancreatic beta -cells (MIN6) via insulin secretion and activation of phosphatidylinositol 3′-kinase. J. Biol. Chem. 275, 36269-36277.
75. Yoshida, K., Murao, K., Imachi, H., Cao, W. M., Yu, X., Li, J., Ahmed, R. A., Kitanaka, N., Wong, N. C., Unterman, T. G., Magnuson, M. A. and Ishida, T. (2007) Pancreatic glucokinase is activated by insulin-like growth factor-I. Endocrinology 148, 2904-2913.
76. Williams, T. F., Exton, J. H., Park, C. R. and Regen, D. M. (1968) Stereospecific transport of glucose in the perfused rat liver. Am. J. Physiol. 215, 1200-1209.
77. Seoane, J., Gomez-Foix, A. M., O'Doherty, R. M., Gomez-Ara, C., Newgard, C. B. and Guinovart, J. J. (1996) Glucose 6-phosphate produced by glucokinase, but not hexokinase I, promotes the activation of hepatic glycogen synthase. J. Biol. Chem. 271, 23756-23760.
78. Agius, L., Peak, M., Newgard, C. B., Gomez-Foix, A. M. and Guinovart, J. J. (1996) Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis. J. Biol. Chem. 271, 30479-30486.
79. Gomis, R. R., Ferrer, J. C. and Guinovart, J. J. (2000) Shared control of hepatic glycogen synthesis by glycogen synthase and glucokinase. Biochem. J. 351 Pt 3, 811-816.
80. Takeuchi, H., Inoue, Y., Ishihara, H. and Oka, Y. (1996) Overexpression of either liver type or pancreatic beta cell type glucokinase via recombinant adenovirus enhances glucose oxidation in isolated rat hepatocytes. FEBS Lett. 393, 60-64.
81. Seoane, J., Barbera, A., Telemaque-Potts, S., Newgard, C. B. and Guinovart, J. J. (1999) Glucokinase overexpression restores glucose utilization and storage in cultured hepatocytes from male Zucker diabetic fatty rats. J. Biol. Chem. 274, 31833-31838.
82. Niswender, K. D., Shiota, M., Postic, C., Cherrington, A. D. and Magnuson, M. A. (1997) Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J. Biol. Chem. 272, 22570-22575.
83. Ferre, T., Pujol, A., Riu, E., Bosch, F. and Valera, A. (1996) Correction of diabetic alterations by glucokinase. Proc. Natl. Acad. Sci. USA 93, 7225-7230.
84. Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D. and Magnuson, M. A. (1999) Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274, 305-315.
85. Rossetti, L., Chen, W., Hu, M., Hawkins, M., Barzilai, N. and Efrat, S. (1997) Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele. Am. J. Physiol. 273, E743-750.
86. Henquin, J. C., Ravier, M. A., Nenquin, M., Jonas, J. C. and Gilon, P. (2003) Hierarchy of the beta-cell signals controlling insulin secretion. Eur. J. Clin. Invest. 33, 742-750.
87. MacDonald, M. J., Fahien, L. A., Brown, L. J., Hasan, N. M., Buss, J. D. and Kendrick, M. A. (2005) Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion. Am. J. Physiol. Endocrinol. Metab. 288, E1-15.
88. Whitesell, R. R., Powers, A. C., Regen, D. M. and Abumrad, N. A. (1991) Transport and metabolism of glucose in an insulin-secreting cell line, beta TC-1. Biochemistry 30, 11560-11566.
89. Tal, M., Liang, Y., Najafi, H., Lodish, H. F. and Matschinsky, F. M. (1992) Expression and function of GLUT-1 and GLUT-2 glucose transporter isoforms in cells of cultured rat pancreatic islets. J. Biol. Chem. 267, 17241-17247.
90. Schuit, F., Moens, K., Heimberg, H. and Pipeleers, D. (1999) Cellular origin of hexokinase in pancreatic islets. J. Biol. Chem. 274, 32803-32809.
91. Wang, H. and Iynedjian, P. B. (1997) Modulation of glucose responsiveness of insulinoma beta-cells by graded overexpression of glucokinase. Proc. Natl. Acad. Sci. USA 94, 4372-4377.
92. Wang, H. and Iynedjian, P. B. (1997) Acute glucose intolerance in insulinoma cells with unbalanced overexpression of glucokinase. J. Biol. Chem. 272, 25731-25736.
93. Berman, H. K. and Newgard, C. B. (1998) Fundamental metabolic differences between hepatocytes and islet beta-cells revealed by glucokinase overexpression. Biochemistry 37, 4543-4552.
94. Terauchi, Y., Sakura, H., Yasuda, K., Iwamoto, K., Takahashi, N., Ito, K., Kasai, H., Suzuki, H., Ueda, O., Kamada, N. and et al. (1995) Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J. Biol. Chem. 270, 30253-30256.
95. Yang, X. J., Kow, L. M., Funabashi, T. and Mobbs, C. V. (1999) Hypothalamic glucose sensor: similarities to and differences from pancreatic beta-cell mechanisms. Diabetes 48, 1763-1772.
96. Roncero, I., Alvarez, E., Vazquez, P. and Blazquez, E. (2000) Functional glucokinase isoforms are expressed in rat brain. J. Neurochem. 74, 1848-1857.
97. Dunn-Meynell, A. A., Routh, V. H., Kang, L., Gaspers, L. and Levin, B. E. (2002) Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 51, 2056-2065.
98. Kang, L., Routh, V. H., Kuzhikandathil, E. V., Gaspers, L. D. and Levin, B. E. (2004) Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 53, 549-559.
99. Kang, L., Dunn-Meynell, A. A., Routh, V. H., Gaspers, L. D., Nagata, Y., Nishimura, T., Eiki, J., Zhang, B. B. and Levin, B. E. (2006) Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes 55, 412-420.
100. Parton, L. E., Ye, C. P., Coppari, R., Enriori, P. J., Choi, B., Zhang, C. Y., Xu, C., Vianna, C. R., Balthasar, N., Lee, C. E., Elmquist, J. K., Cowley, M. A. and Lowell, B. B. (2007) Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449, 228-232.
101. Wolfgang, M. J. and Lane, M. D. (2006) The role of hypothalamic malonyl-CoA in energy homeostasis. J. Biol. Chem. 281, 37265-37269.
102. Velho, G., Blanche, H., Vaxillaire, M., Bellanne-Chantelot, C., Pardini, V. C., Timsit, J., Passa, P., Deschamps, I., Robert, J. J., Weber, I. T., Marotta, D., Pilkis, S. J., Lipkind, G. M., Bell, G. I. and Froguel, P. (1997) Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 40, 217-224.
103. Fajans, S. S., Bell, G. I. and Polonsky, K. S. (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345, 971-980.
104. Ellard, S., Beards, F., Allen, L. I., Shepherd, M., Ballantyne, E., Harvey, R. and Hattersley, A. T. (2000) A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 43, 250-253.
105. Murphy, R., Ellard, S. and Hattersley, A. T. (2008) Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol. Metab. 4, 200-213.
106. Njolstad, P. R., Sagen, J. V., Bjorkhaug, L., Odili, S., Shehadeh, N., Bakry, D., Sarici, S. U., Alpay, F., Molnes, J., Molven, A., Sovik, O. and Matschinsky, F. M. (2003) Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes 52, 2854-2860.
107. Velho, G., Petersen, K. F., Perseghin, G., Hwang, J. H., Rothman, D. L., Pueyo, M. E., Cline, G. W., Froguel, P. and Shulman, G. I. (1996) Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J. Clin. Invest. 98, 1755-1761.
108. Tappy, L., Dussoix, P., Iynedjian, P., Henry, S., Schneiter, P., Zahnd, G., Jequier, E. and Philippe, J. (1997) Abnormal regulation of hepatic glucose output in maturity-onset diabetes of the young caused by a specific mutation of the glucokinase gene. Diabetes 46, 204-208.
109. Byrne, M. M., Sturis, J., Clement, K., Vionnet, N., Pueyo, M. E., Stoffel, M., Takeda, J., Passa, P., Cohen, D., Bell, G. I. and et al. (1994) Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J. Clin. Invest. 93, 1120-1130.
110. Miller, S. P., Anand, G. R., Karschnia, E. J., Bell, G. I., LaPorte, D. C. and Lange, A. J. (1999) Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype. Diabetes 48, 1645-1651.
111. Davis, E. A., Cuesta-Munoz, A., Raoul, M., Buettger, C., Sweet, I., Moates, M., Magnuson, M. A. and Matschinsky, F. M. (1999) Mutants of glucokinase cause hypoglycaemia and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis. Diabetologia 42, 1175-1186.
112. Galan, M., Vincent, O., Roncero, I., Azriel, S., Boix-Pallares, P., Delgado-Alvarez, E., Diaz-Cadorniga, F., Blazquez, E. and Navas, M. A. (2006) Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability. Biochem. J. 393, 389-396.
113. Burke, C. V., Buettger, C. W., Davis, E. A., McClane, S. J., Matschinsky, F. M. and Raper, S. E. (1999) Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI). Biochem. J. 342 (Pt 2), 345-352.
114. Toye, A. A., Moir, L., Hugill, A., Bentley, L., Quarterman, J., Mijat, V., Hough, T., Goldsworthy, M., Haynes, A., Hunter, A. J., Browne, M., Spurr, N. and Cox, R. D. (2004) A new mouse model of type 2 diabetes, produced by N-ethyl-nitrosourea mutagenesis, is the result of a missense mutation in the glucokinase gene. Diabetes 53, 1577-1583.
115. Aigner, B., Rathkolb, B., Herbach, N., Hrabe de Angelis, M., Wanke, R. and Wolf, E. (2008) Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects. Am. J. Physiol. Endocrinol. Metab. 294, E232-240.
116. Inoue, M., Sakuraba, Y., Motegi, H., Kubota, N., Toki, H., Matsui, J., Toyoda, Y., Miwa, I., Terauchi, Y., Kadowaki, T., Shigeyama, Y., Kasuga, M., Adachi, T., Fujimoto, N., Matsumoto, R., Tsuchihashi, K., Kagami, T., Inoue, A., Kaneda, H., Ishijima, J., Masuya, H., Suzuki, T., Wakana, S., Gondo, Y., Minowa, O., Shiroishi, T. and Noda, T. (2004) A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program. Hum. Mol. Genet. 13, 1147-1157.
117. Glaser, B., Kesavan, P., Heyman, M., Davis, E., Cuesta, A., Buchs, A., Stanley, C. A., Thornton, P. S., Permutt, M. A., Matschinsky, F. M. and Herold, K. C. (1998) Familial hyperinsulinism caused by an activating glucokinase mutation. N. Engl. J. Med. 338, 226-230.
118. Gloyn, A. L., Noordam, K., Willemsen, M. A., Ellard, S., Lam, W. W., Campbell, I. W., Midgley, P., Shiota, C., Buettger, C., Magnuson, M. A., Matschinsky, F. M. and Hattersley, A. T. (2003) Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes 52, 2433-2440.
119. Cuesta-Munoz, A. L., Huopio, H., Otonkoski, T., Gomez-Zumaquero, J. M., Nanto-Salonen, K., Rahier, J., Lopez-Enriquez, S., Garcia-Gimeno, M. A., Sanz, P., Soriguer, F. C. and Laakso, M. (2004) Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes 53, 2164-2168.
120. Wabitsch, M., Lahr, G., Van de Bunt, M., Marchant, C., Lindner, M., von Puttkamer, J., Fenneberg, A., Debatin, K. M., Klein, R., Ellard, S., Clark, A. and Gloyn, A. L. (2007) Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy. Diabet. Med. 24, 1393-1399.
121. Pino, M. F., Kim, K. A., Shelton, K. D., Lindner, J., Odili, S., Li, C., Collins, H. W., Shiota, M., Matschinsky, F. M. and Magnuson, M. A. (2007) Glucokinase thermolability and hepatic regulatory protein binding are essential factors for predicting the blood glucose phenotype of missense mutations. J. Biol. Chem. 282, 13906-13916.
122. Muoio, D. M. and Newgard, C. B. (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell. Biol. 9, 193-205.
123. Grimsby, J., Sarabu, R., Corbett, W. L., Haynes, N. E., Bizzarro, F. T., Coffey, J. W., Guertin, K. R., Hilliard, D. W., Kester, R. F., Mahaney, P. E., Marcus, L., Qi, L., Spence, C. L., Tengi, J., Magnuson, M. A., Chu, C. A., Dvorozniak, M. T., Matschinsky, F. M. and Grippo, J. F. (2003) Allosteric activators of glucokinase: potential role in diabetes therapy. Science 301, 370-373.
124. Brocklehurst, K. J., Payne, V. A., Davies, R. A., Carroll, D., Vertigan, H. L., Wightman, H. J., Aiston, S., Waddell, I. D., Leighton, B., Coghlan, M. P. and Agius, L. (2004) Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators. Diabetes 53, 535-541.
125. Efanov, A. M., Barrett, D. G., Brenner, M. B., Briggs, S. L., Delaunois, A., Durbin, J. D., Giese, U., Guo, H., Radloff, M., Gil, G. S., Sewing, S., Wang, Y., Weichert, A., Zaliani, A. and Gromada, J. (2005) A novel glucokinase activator modulates pancreatic islet and hepatocyte function. Endocrinology 146, 3696-3701.
126. Fyfe, M. C., White, J. R., Taylor, A., Chatfield, R., Wargent, E., Printz, R. L., Sulpice, T., McCormack, J. G., Procter, M. J., Reynet, C., Widdowson, P. S. and Wong-Kai-In, P. (2007) Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions. Diabetologia 50, 1277-1287.
127. Coghlan, M. and Leighton, B. (2008) Glucokinase activators in diabetes management. Expert Opin. Investig. Drugs 17, 145-167.
128. O'Doherty, R. M., Lehman, D. L., Telemaque-Potts, S. and Newgard, C. B. (1999) Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes 48, 2022-2027.
129. Ferre, T., Riu, E., Franckhauser, S., Agudo, J. and Bosch, F. (2003) Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance. Diabetologia 46, 1662-1668.
130. Aston-Mourney, K., Proietto, J., Morahan, G. and Andrikopoulos, S. (2008) Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin. Diabetologia 51, 540-545.